ASPI

1.1003.08%
DM

Duncan Moore

Independent Non-Executive Director

Dr. Duncan Moore, B.Sc., Ph.D., is Independent Non-Executive Director of GH Research PLC from September 24, 2021. Dr. Moore serves as Partner at East West Capital Partners. Dr. Moore formally joined East West Capital Partners in May 2008 having served informally as an advisor since early 2007. He Chairs the Scottish Lifesciences Association. He is also an investor director of Cambridge based rare disease company Cycle Pharma, Duncan was a top ranked pharmaceutical analyst at Morgan Stanley from 1991 to 2008 and was a Managing Director from 1997 to 2008 leading the firm’s global healthcare equity research team. He was the lead analyst on the European pharmaceutical industry stocks and led the equity research part of the initial public offerings of numerous companies including Wellcome PLC, Sulzer Medica, Biora, deCODE Genetics, Almirall, Grifols and Whilst at the University of Cambridge he co-founded a medical diagnostics company called Ultra Clone with two colleagues which led to the beginnings of a 20 year career in healthcare capital markets analysis. In 1986 he was involved in setting up the Bank Invest biotechnology funds and was a member of the scientific advisory board. Duncan was educated in Edinburgh and went to the University of Leeds where he studied Biochemistry and Microbiology. He has an M.Phil and Ph.D. from the University of Cambridge where he was also a post doctoral research fellow. He serves as an Independent Director of ASP Isotopes Inc., since October 2021.

Positions